My caption 😄
A Molecular Take on Malignant Rhabdoid Tumors
Abstract
The molecular basis for the clinical heterogeneity observed in patients with malignant rhabdoid tumors is unknown. Recently, two reports revealed molecular intertumor heterogeneity in teratoid/rhabdoid tumors (ATRTs) and extra-cranial MRTs (ecMRTs) using genomic, transcriptomic, and epigenomic profiling. Distinct molecular subgroups were identified and new therapeutic targets were revealed.
Type
Publication
In Trends in Cancer, Trends in Cancer.
Date
May, 2016
Links
More detail can easily be written here using Markdown and $\rm \LaTeX$ math code.